Rapamycin increases survival in ALS mice lacking mature lymphocytes

Molecular Neurodegeneration

Volumn 8, Issue 1, 2013, Pages

  Staats, Kim A ^a,b   Hernandez, Sara ^a,b   Schönefeldt, Susann ^a,b   Bento Abreu, André ^a,b   Dooley, James ^a,b   Van Damme, Philip ^a,b,c   Liston, Adrian ^a,b   Robberecht, Wim ^a,b,c   Van Den Bosch, Ludo ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Amyotrophic lateral sclerosis; Autophagy; Immunosuppression; Motor neuron disease; Neurodegeneration; Rapamune; Rapamycin; Sirolimus

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MICROTUBULE ASSOCIATED PROTEIN; RAPAMYCIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CELL FUNCTION; CELL MATURATION; CONCENTRATION RESPONSE; DIET RESTRICTION; DIET SUPPLEMENTATION; IMMUNE DEFICIENCY; LIGHT CHAIN; LYMPHOCYTE; MOUSE; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SPINAL CORD; SURVIVAL; T LYMPHOCYTE;

MUS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AUTOPHAGY; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIROLIMUS; SPINAL CORD;

EID: 84883637335     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-8-31     Document Type: Article

References (25)

1. Incidence of amyotrophic lateral sclerosis in Europe. Logroscino G, Traynor BJ, Hardiman O, Chio A, Mitchell D, Swingler RJ, Millul A, Benn E, Beghi E, J Neurol Neurosurg Psychiatry 2010 81 385 390 10.1136/jnnp.2009.183525 19710046
2. Transgenic mouse models of amyotrophic lateral sclerosis. Julien JP, Kriz J, Biochim Biophys Acta 2006 1762 1013 1024 10.1016/j.bbadis.2006.03.006 16675207 (Pubitemid 44750574)
3. Protein aggregation and defective RNA metabolism as mechanisms for motor neuron damage. Ticozzi N, Ratti A, Silani V, CNS Neurol Disord Drug Targets 2010 9 285 296 10.2174/187152710791292585 20406182
4. Protein misdirection inside and outside motor neurons in amyotrophic lateral sclerosis (ALS): a possible clue for therapeutic strategies. Ido A, Fukuyama H, Urushitani M, Int J Mol Sci 2011 12 6980 7003 10.3390/ijms12106980 22072931
5. Processing of optineurin in neuronal cells. Shen X, Ying H, Qiu Y, Park JS, Shyam R, Chi ZL, Iwata T, Yue BY, J Biol Chem 2011 286 3618 3629 10.1074/jbc.M110.175810 21059646
6. Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes. Miyakawa T, Maeda A, Yamazawa T, Hirose K, Kurosaki T, Iino M, EMBO J 1999 18 1303 1308 10.1093/emboj/18.5.1303 10064596 (Pubitemid 29110314)
7. In vivo optical imaging of motor neuron autophagy in a mouse model of amyotrophic lateral sclerosis. Tian F, Morimoto N, Liu W, Ohta Y, Deguchi K, Miyazaki K, Abe K, Autophagy 2011 7 985 992 10.4161/auto.7.9.16012 21628996
8. Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Morimoto N, Nagai M, Ohta Y, Miyazaki K, Kurata T, Morimoto M, Murakami T, Takehisa Y, Ikeda Y, Kamiya T, Abe K, Brain Res 2007 1167 112 117 17689501 (Pubitemid 47302432)
9. Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. Sasaki S, J Neuropathol Exp Neurol 2011 70 349 359 10.1097/NEN.0b013e3182160690 21487309
10. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. Spencer B, Potkar R, Trejo M, Rockenstein E, Patrick C, Gindi R, Adame A, Wyss-Coray T, Masliah E, J Neurosci 2009 29 13578 13588 10.1523/JNEUROSCI.4390-09.2009 19864570
11. Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Menzies FM, Huebener J, Renna M, Bonin M, Riess O, Rubinsztein DC, Brain 2010 133 93 104 10.1093/brain/awp292 20007218
12. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O'Kane CJ, Rubinsztein DC, Nat Genet 2004 36 585 595 10.1038/ng1362 15146184 (Pubitemid 38715985)
13. Autophagy activators rescue and alleviate pathogenesis of a mouse model with proteinopathies of the TAR DNA-binding protein 43. Wang IF, Guo BS, Liu YC, Wu CC, Yang CH, Tsai KJ, Shen CK, Proc Natl Acad Sci USA 2012 109 15024 15029 10.1073/pnas.1206362109 22932872
14. XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Hetz C, Thielen P, Matus S, Nassif M, Court F, Kiffin R, Martinez G, Cuervo AM, Brown RH, Glimcher LH, Genes Dev 2009 23 2294 2306 10.1101/gad.1830709 19762508
15. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Heitman J, Movva NR, Hall MN, Science 1991 253 905 909 10.1126/science.1715094 1715094 (Pubitemid 21917235)
16. Dietary restriction but not rapamycin extends disease onset and survival of the H46R/H48Q mouse model of ALS. Bhattacharya A, Bokov A, Muller FL, Jernigan AL, Maslin K, Diaz V, Richardson A, Van Remmen H, Neurobiol Aging 2012 33 1829 1832 10.1016/j.neurobiolaging.2011.06.002 21763036
17. Immunoregulatory functions of mTOR inhibition. Thomson AW, Turnquist HR, Raimondi G, Nat Rev Immunol 2009 9 324 337 10.1038/nri2546 19390566
18. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Chiu IM, Chen A, Zheng Y, Kosaras B, Tsiftsoglou SA, Vartanian TK, Brown RH Jr, Carroll MC, Proc Natl Acad Sci USA 2008 105 17913 17918 10.1073/pnas.0804610105 18997009
19. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Beers DR, Henkel JS, Zhao W, Wang J, Appel SH, Proc Natl Acad Sci USA 2008 105 15558 15563 10.1073/pnas.0807419105 18809917
20. Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis. Patel BP, Hamadeh MJ, Clin Nutr 2009 28 604 617 10.1016/j.clnu.2009.06.002 19782443
21. Caloric restriction. Speakman JR, Mitchell SE, Mol Aspects Med 2011 32 159 221 10.1016/j.mam.2011.07.001 21840335
22. RAG-1-deficient mice have no mature B and T lymphocytes. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE, Cell 1992 68 869 877 10.1016/0092-8674(92)90030-G 1547488
23. Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis. Beers DR, Henkel JS, Zhao W, Wang J, Huang A, Wen S, Liao B, Appel SH, Brain 2011 134 1293 1314 10.1093/brain/awr074 21596768
24. mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy. Ching JK, Elizabeth SV, Ju JS, Lusk C, Pittman SK, Weihl CC, Hum Mol Genet 2013 22 1167 1179 10.1093/hmg/dds524 23250913
25. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, et al. Nature 2009 460 392 395 19587680